<DOC>
	<DOC>NCT02182739</DOC>
	<brief_summary>Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.</brief_summary>
	<brief_title>Observational Study of Meloxicam in Any Labeled Indication</brief_title>
	<detailed_description />
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Patients according to the physicians medical criteria on the labeled indications for Meloxicam</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>